Quality of life in non-metastasic colorectal cancer patients in FOLFOX or XELOX therapy.

CONCLUSIONS: Patients with XELOX scheme referred to have worse  emotionally status in the middle of the adjuvant treatment than patients  treated with FOLFOX scheme and presented a worsening in items fatigue,  nausea, vomiting, anorexia and diarrhoea. PMID: 30848178 [PubMed - in process]
Source: Farmacia Hospitalaria - Category: Drugs & Pharmacology Authors: Tags: Farm Hosp Source Type: research